AMRS · Amyris, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $269.85M | $341.82M | $173.14M | $152.56M | $63.60M | $143.44M |
| Cost of Revenue | $258.67M | $155.14M | $87.81M | $76.19M | $62.31M | - |
| Gross Profit | $11.18M | $186.68M | $85.33M | $76.37M | $1.30M | - |
| R&D | $110.22M | $94.29M | $71.68M | $71.46M | $68.72M | $56.96M |
| SG&A | $493.63M | $257.81M | $137.07M | $126.59M | $90.90M | $63.29M |
| Total Operating Expenses | $838.83M | $519.44M | $296.56M | $274.45M | $200.19M | $182.96M |
| D&A | $12.37M | $8.74M | $9.37M | $4.58M | $4.92M | $11.36M |
| Operating Income | ($568.98M) | ($177.63M) | ($123.42M) | ($121.89M) | ($136.58M) | ($39.52M) |
| Interest Expense | $24.73M | $25.61M | $47.95M | $58.66M | $42.70M | $34.03M |
| Income Tax | ($2.70M) | ($8.11M) | $293.0K | $0 | - | $295.0K |
| Net Income | ($528.51M) | ($270.97M) | ($331.04M) | ($242.77M) | ($230.24M) | ($72.33M) |
| EPS - Basic | ($1.65) | ($0.93) | ($1.88) | ($3.69) | - | ($2.89) |
| EPS - Diluted | ($1.69) | ($0.97) | ($1.88) | ($3.69) | - | ($2.89) |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $64.44M | $483.46M | $30.15M | $270.0K | $45.35M | $57.06M |
| Accounts Receivable | - | - | - | - | - | $33.62M |
| Inventory | $111.88M | $75.07M | $42.86M | $27.77M | $9.69M | $5.41M |
| Accounts Payable | $190.49M | $79.67M | $41.05M | $51.23M | $26.84M | $15.92M |
| Current Assets | $306.36M | $639.21M | $146.56M | $73.61M | $92.22M | $104.61M |
| Total Assets | $824.93M | $954.30M | $222.81M | $160.97M | $127.92M | $151.48M |
| Current Liabilities | $387.15M | $269.81M | $163.05M | $161.14M | $211.74M | $107.15M |
| Long-term Debt | $674.89M | $309.06M | $26.17M | $48.45M | $43.33M | $61.89M |
| Total Liabilities | $1.29B | $675.09M | $389.86M | $411.13M | $339.74M | $346.19M |
| Stockholders' Equity | ($488.69M) | $246.44M | ($176.82M) | ($255.78M) | ($217.76M) | ($200.64M) |
| Retained Earnings | ($2.88B) | ($2.36B) | ($2.09B) | ($1.76B) | ($1.52B) | ($1.21B) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($525.89M) | ($181.33M) | ($175.75M) | ($156.93M) | ($109.37M) | ($82.37M) |
| Investing Cash Flow | ($123.71M) | ($64.10M) | ($12.78M) | ($13.08M) | ($12.47M) | $5.64M |
| Financing Cash Flow | $231.41M | $701.96M | $222.53M | $124.91M | $107.96M | $92.20M |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 4.1% | 54.6% | 49.3% | 50.1% | 2.0% | - |
| Operating margin | -210.9% | -52.0% | -71.3% | -79.9% | -214.7% | -27.5% |
| EBITDA margin | -206.3% | -49.4% | -65.9% | -76.9% | -207.0% | -19.6% |
| Net margin | -195.9% | -79.3% | -191.2% | -159.1% | -362.0% | -50.4% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | 40.8% | 27.6% | 41.4% | 46.8% | 108.0% | 39.7% |
| SG&A / Revenue | 182.9% | 75.4% | 79.2% | 83.0% | 142.9% | 44.1% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -64.1% | -28.4% | -148.6% | -150.8% | -180.0% | -47.7% |
| Return on equity | 108.1% | -110.0% | 187.2% | 94.9% | 105.7% | 36.0% |
| Return on invested capital | -241.4% | -25.3% | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 0.79 | 2.37 | 0.90 | 0.46 | 0.44 | 0.98 |
| Quick ratio | 0.50 | 2.09 | 0.64 | 0.28 | 0.39 | 0.93 |
| Cash ratio | 0.17 | 1.79 | 0.18 | 0.00 | 0.21 | 0.53 |
| Leverage | ||||||
| Debt / Equity | -1.38 | 1.25 | -0.15 | -0.19 | -0.20 | -0.31 |
| Debt / Assets | 0.82 | 0.32 | 0.12 | 0.30 | 0.34 | 0.41 |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -23.0x | -6.9x | -2.6x | -2.1x | -3.2x | -1.2x |
| Equity multiplier | -1.69 | 3.87 | -1.26 | -0.63 | -0.59 | -0.75 |
| Liabilities / Assets | 1.57 | 0.71 | 1.75 | 2.55 | 2.66 | 2.29 |
| Efficiency | ||||||
| Asset turnover | 0.33 | 0.36 | 0.78 | 0.95 | 0.50 | 0.95 |
| Inventory turnover | 2.31 | 2.07 | 2.05 | 2.74 | 6.43 | - |
| Days sales outstanding | - | - | - | - | - | 86d |
| Days inventory outstanding | 158d | 177d | 178d | 133d | 57d | - |
| Days payable outstanding | 269d | 187d | 171d | 245d | 157d | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -21.1% | 97.4% | 13.5% | 139.9% | -55.7% | 113.5% |
| Revenue CAGR (3y) | 20.9% | 75.2% | 6.5% | 31.4% | 23.0% | 49.1% |
| Revenue CAGR (5y) | 13.5% | 38.5% | 38.4% | 28.7% | 9.1% | 14.2% |
| Gross profit growth (YoY) | -94.0% | 118.8% | 11.7% | 5788.4% | - | - |
| Operating income growth (YoY) | -220.3% | -43.9% | -1.3% | 10.8% | -245.6% | 58.8% |
| Net income growth (YoY) | -95.0% | 18.1% | -36.4% | -5.4% | -218.3% | 25.7% |
| EPS growth (YoY) | -74.2% | 48.4% | 49.1% | - | - | -556.8% |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | 30.9% | -17.5% | -8.5% | -8.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$179.77M totalLicenses And Royalties$149.61M · 83.2%
Renewable Products$19.16M · 10.7%
Grants And Collaborations$6.00M · 3.3%
License$5.00M · 2.8%
Stability scores
Altman Z′
FY 2022 · bankruptcy risk
-5.00
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2022 · 9-point quality
1/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Industrial Organic Chemicals
Comparing AMYRIS against the 5 most active filers in the same SIC group.